Personal profile

Biography

Dr. Cathy Xie is currently serving as a research fellow at the Australian Translational Medicinal Chemistry Facility (ATMCF), affiliated with the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University.

Throughout her career, Cathy has maintained a steadfast commitment to drug discovery and research commercialisation, actively contributing to various projects.

Cathy earned her doctorate degree in Medicinal Chemistry from Monash University in 2020. Her thesis focused on the development of GSTO1-1 inhibitors for the treatment of inflammatory conditions.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Medicinal Chemistry, Doctor of Philosophy, Development of GSTO1-1 inhibitors for the treatment of inflammatory conditions, MONASH UNIVERSITY

30 Sept 20162 Apr 2020

Award Date: 2 Apr 2020

Pharmaceutical Sciences, Bachelor of Science, China Pharmaceutical University

1 Sept 201230 Jun 2016

Award Date: 30 Jun 2016

Research area keywords

  • Drug Discovery
  • Medicinal Chemistry
  • Chemical Biology
  • Drug Development

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or